![1]()
News
Growing evidence supports repurposing antidepressants to treat COVID-19
November 19, 2021
“We can’t tell if the drugs are causing these effects, but the statistical analysis is showing significant association,” said Dr. Marina Sirota.
![1]()
News
Empagliflozin a winner in challenging arena of stabilized acute HF
November 19, 2021
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of their ejection fraction, says an expert observer.
News
Faster testing possible for secondary ICU infections
November 18, 2021
Researchers have shown the potential for clinical metagenomics to become a same-day test for identifying secondary infection in ventilated ICU patients.
![1]()
News
Hospitalists helped plan COVID-19 field hospitals
November 18, 2021
Better to plan for too much than not plan for enough, say hospitalists who helped build COVID-19 field hospitals.
![1]()
News
U.S. overdose deaths hit an all-time high
November 18, 2021
Fentanyl and methamphetamine are contributing to rising numbers of fatalities, federal officials say.
![1]()
News
Timing of endoscopy for acute upper GI bleeding
November 18, 2021
In high-risk patients hospitalized with upper GI bleeding, is earlier endoscopy beneficial?
News
Text-based COVID monitoring system could reduce deaths, relieve ED in winter surge
November 17, 2021
The new program could play a role in decreasing disparities in COVID outcomes, says an investigator.
![1]()
News
Early rhythm control in atrial fibrillation (EAST-AFNET trial)
November 17, 2021
Is rhythm control superior to rate control in treating early atrial fibrillation (AFib)?
![1]()
News
EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
November 17, 2021
A landmark trial proved empagliflozin’s efficacy in HFpEF, but many patients had “moderately reduced” EFs. The findings hold up even without them.
![1]()
News
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
November 17, 2021
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a phase 3 trial.
